Table 1.
Characteristics | Summary Statistics |
---|---|
Male sex, n (%) | 8 (21%) |
Age (y) | |
Mean ± SD | 46.7 ± 12.9 |
Median (range) | 48 (16–71) |
Duration of disease (mo) | |
Mean ± SD | 75.7 ± 90.7 |
Median (range) | 48 (1–350) |
Laterality of uveitis, n (%) | |
Unilateral | 12 (31%) |
Bilateral | 27 (69%) |
Active uveitis at time of sampling, n (%) | 26 (67%) |
Medication at time of sampling, n (%)* | |
None | 7 (18%) |
Topical corticosteroids only | 25 (64%) |
Systemic medication (with or without topical corticosteroids) | 7 (18%) |
Prior intraocular surgery, n (%)† | 2 (5.1%) |
Uveitis diagnosis, n (%) | |
Idiopathic anterior uveitis | 27 (67%) |
HLA-B27 associated anterior uveitis | 8 (21%) |
Vogt-Koyanagi-Harada | 2 (5%) |
Sarcoidosis | 1 (3%) |
Juvenile idiopathic arthritis | 1 (3%) |
Including three patients on systemic corticosteroids, four patients on methotrexate, three patients on cyclosporine, and one patient on infliximab.
Including two patients who had drainage device implants.